Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney disease
kidney disease
FDA approves Amgen drug for secondary hyperparathyroidism
Yahoo/Reuters
Wed, 02/8/17 - 09:18 am
FDA
Amgen
secondary hyperparathyroidism
kidney disease
etelcalcetide
GlaxoSmithKline Launches Anemia Drug Trial
Investopedia
Sun, 11/27/16 - 03:55 pm
GSK
clinical trials
daprodustat
anemia
kidney disease
Omeros Kidney Drug Reports Good Results
Investopedia
Tue, 10/18/16 - 09:21 am
Omeros
OMS721
kidney disease
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Wed, 09/7/16 - 10:04 am
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis
Keryx Biopharmaceuticals says kidney disease drug won't be available until the fourth quarter; stock halted
Marketwatch
Mon, 08/1/16 - 09:38 am
Keryx
kidney disease
Auryxia
FibroGen Has The Look Of A Long-Term Biotech Winner
Seeking Alpha
Sun, 07/10/16 - 12:32 pm
FibroGen
roxadustat
kidney disease
Opko wins approval for kidney drug after manufacturing snag
BioPharma Dive
Thu, 06/23/16 - 08:13 pm
OPKO Health
Rayaldee
FDA
secondary hyperparathyroidism
kidney disease
Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit
BioPharma Dive
Wed, 06/15/16 - 05:42 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
kidney disease
Opko Health stock falls 10% after drug approval faces delay
Bizjournals.com
Wed, 03/30/16 - 09:21 pm
FDA
OPKO Health
Rayaldee
kidney disease
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
Bizjournals.com
Wed, 03/9/16 - 09:18 am
FDA
fast track
Omeros
OMS721
kidney disease
Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Bizjournals.com
Wed, 09/9/15 - 10:02 pm
Akebia Therapeutics
anemia
vadadustat
kidney disease
Amgen's AMG 416 Succeeds in Phase III, Shares Up
Yahoo/Zacks.com
Mon, 07/21/14 - 03:38 pm
Amgen
AMG 416
kidney disease
IPO Preview: NephroGenex
Seeking Alpha
Fri, 02/7/14 - 09:28 am
IPOs
NephroGenex
kidney disease
AstraZeneca Boasts of Pipeline as Analysts See Deal Ahead
Bloomberg
Fri, 02/7/14 - 09:22 am
AstraZeneca
roxadustat
kidney disease
non-small cell lung cancer
AZD9291
What To Know About Questcor Pharmaceuticals' Most Important Drug
Motley Fool
Thu, 01/23/14 - 09:37 am
Questcor Pharmaceuticals
Acthar
multiple sclerosis
kidney disease
rheumatology
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Fri, 01/10/14 - 06:58 pm
Amgen
Atara
Series B
oncology
kidney disease
Evotec, AstraZeneca in Kidney Disease Alliance
Contract Pharma
Tue, 10/22/13 - 08:16 am
kidney disease
AstraZeneca
Evotec
Amgen Benefits From Affymax Recall
Seeking Alpha
Tue, 03/5/13 - 11:58 am
Amgen
Affymax
recalls
Omontys
Takeda
kidney disease
Zerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals
Motley Fool
Mon, 02/11/13 - 08:16 am
Keryx
Zerenex
kidney disease
A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement
Seeking Alpha
Tue, 02/5/13 - 10:28 am
Keryx
kidney disease
Zerenex
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »